SNCA and early-onset autosomal dominant Alzheimer disease: Interestingly, α-synuclein is now also implicated in reducing Aβ deposition and plaque formation in Alzheimer’s disease, although the interaction between α-synuclein and Aβ does not seem to attenuate, but rather exacerbate, synapse and dendritic loss [47].